HCC
VIAV icon

Hirtle Callaghan & Co’s Viavi Solutions VIAV Stock Holding History

Hirtle Callaghan & Co’s Portfolio VIAV Stock Details VIAV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-4,395
Closed -$37K – 653
2013
Q3 		$37K Buy
+4,395
New +$36.1K 0.01% 378

Other funds holding VIAV

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TCIM
TIAA CREF Investment Management New York $141B AUM 14.18% 1-Year Est. Return
TA
Teachers Advisors New York $81.7B AUM 13.62% 1-Year Est. Return

Hirtle Callaghan & Co's VIAV Position: Q4 2013 in Review

Hirtle Callaghan & Co sold out of Viavi Solutions (VIAV) in Q4 2013, closing a stake of 4,395 shares — an estimated $37K sold.

Hirtle Callaghan & Co first reported a position in VIAV in Q3 2013 and held it in 1 quarter. The position peaked at $37K in Q3 2013. 276 funds tracked by Wall St. Rank hold VIAV as of Q4 2013.

  • Hirtle Callaghan & Co reported no remaining Viavi Solutions position as of Q4 2013 after selling out during the quarter.
  • Hirtle Callaghan & Co sold 4,395 Viavi Solutions shares in Q4 2013, an estimated $37K.
  • Hirtle Callaghan & Co first reported a position in Viavi Solutions in Q3 2013 and held it in 1 quarter.
  • Hirtle Callaghan & Co's Viavi Solutions position peaked at $37K in Q3 2013.
  • 276 funds tracked by Wall St. Rank held Viavi Solutions as of Q4 2013.

Based on Hirtle Callaghan & Co's 13F filing for Q4 2013, filed 29 Jan 2014.